17.14
前日終値:
$17.06
開ける:
$16.91
24時間の取引高:
329.48K
Relative Volume:
0.60
時価総額:
$1.04B
収益:
$1.23M
当期純損益:
$-214.90M
株価収益率:
-4.158
EPS:
-4.1222
ネットキャッシュフロー:
$-151.25M
1週間 パフォーマンス:
+4.83%
1か月 パフォーマンス:
-3.65%
6か月 パフォーマンス:
-6.70%
1年 パフォーマンス:
-38.37%
Spyre Therapeutics Inc Stock (SYRE) Company Profile
SYRE を他の銘柄と比較する
株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
---|---|---|---|---|---|---|
![]()
SYRE
Spyre Therapeutics Inc
|
17.14 | 1.03B | 1.23M | -214.90M | -151.25M | -4.1222 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
389.08 | 99.27B | 11.39B | 3.64B | 3.50B | 13.99 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
586.96 | 62.28B | 14.21B | 4.46B | 3.56B | 39.68 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
454.18 | 59.14B | 2.46B | -319.09M | -52.09M | -2.47 |
![]()
ARGX
Argen X Se Adr
|
707.96 | 43.34B | 3.06B | 1.28B | 447.35M | 21.30 |
![]()
ONC
Beone Medicines Ltd Adr
|
300.14 | 36.72B | 3.81B | -644.79M | -669.77M | -6.24 |
Spyre Therapeutics Inc Stock (SYRE) Upgrades & Downgrades
日付 | アクション | アナリスト | 評価の変更 |
---|---|---|---|
2025-04-08 | 開始されました | Leerink Partners | Outperform |
2025-03-18 | 開始されました | Wolfe Research | Outperform |
2024-09-04 | 開始されました | Wedbush | Outperform |
2024-07-16 | 開始されました | Evercore ISI | Outperform |
2024-05-02 | 開始されました | Robert W. Baird | Outperform |
2024-03-01 | アップグレード | Wells Fargo | Equal Weight → Overweight |
2023-12-20 | 開始されました | BTIG Research | Buy |
2023-12-11 | 開始されました | Guggenheim | Buy |
2023-12-11 | 開始されました | Jefferies | Buy |
2020-05-04 | 開始されました | Piper Sandler | Overweight |
2019-03-21 | 開始されました | JP Morgan | Overweight |
2018-09-04 | ダウングレード | Wells Fargo | Outperform → Market Perform |
2018-04-24 | 開始されました | Evercore ISI | Outperform |
2018-03-14 | 繰り返されました | Needham | Buy |
すべてを表示
Spyre Therapeutics Inc (SYRE) 最新ニュース
Real time scanner hits for Spyre Therapeutics Inc. explainedGold Moves & AI Forecast for Swing Trade Picks - Newser
What technical models suggest about Spyre Therapeutics Inc.’s comeback - Newser
Is Spyre Therapeutics Inc. trending in predictive chart modelsQuarterly Profit Review & Accurate Buy Signal Alerts - Newser
Market reaction to Spyre Therapeutics Inc.’s recent news2025 Year in Review & Fast Exit and Entry Strategy Plans - Newser
Long term hold vs stop loss in Spyre Therapeutics Inc.Weekly Trade Analysis & Reliable Trade Execution Plans - Newser
Relative strength of Spyre Therapeutics Inc. in sector analysisAnalyst Upgrade & Free Expert Verified Stock Movement Alerts - Newser
Spyre Therapeutics Inc. stock trend forecastJuly 2025 Analyst Calls & Precise Buy Zone Tips - Newser
What data driven models say about Spyre Therapeutics Inc.’s futureGap Up & Consistent Profit Focused Trading Strategies - Newser
Can Spyre Therapeutics Inc. recover in the next quarterQuarterly Portfolio Review & Proven Capital Preservation Methods - Newser
Is Spyre Therapeutics Inc. forming a bottoming baseTrade Signal Summary & Free Accurate Trade Setup Notifications - Newser
Published on: 2025-08-25 08:43:40 - Newser
Using flow based indicators on Spyre Therapeutics Inc.Weekly Risk Summary & Growth Focused Stock Reports - Newser
Combining machine learning predictions for Spyre Therapeutics Inc.Earnings Risk Summary & Reliable Trade Execution Plans - Newser
Traders Consider Averaging Down in Spyre Therapeutics Inc.2025 Macro Impact & Step-by-Step Swing Trade Plans - newsyoung.net
Activity Recap: What’s the RSI of Spyre Therapeutics Inc. stock2025 Key Highlights & Free Community Consensus Stock Picks - sundaytimes.kr
Is Spyre Therapeutics Inc. stock technically oversoldJuly 2025 Rallies & Risk Controlled Stock Alerts - sundaytimes.kr
Will Spyre Therapeutics Inc. bounce back from current supportProduct Launch & Real-Time Stock Movement Alerts - Newser
What is Spyre Therapeutics Inc.’s valuation compared to sector2025 Market Sentiment & Community Verified Trade Alerts - theviewers.co.kr
FOMO Trade: What are the future prospects of Spyre Therapeutics Inc.Market Growth Report & AI Driven Stock Price Forecasts - sundaytimes.kr
Spyre Therapeutics Inc. stock trend outlook and recovery path2025 Market Overview & Accurate Buy Signal Alerts - Newser
Does Spyre Therapeutics Inc. have high return on assetsDay Trade & Verified Technical Signals - theviewers.co.kr
Spyre Therapeutics Bets Big On Next-Gen IBD Pipeline - Finimize
Can Spyre Therapeutics Inc. expand its profit marginsEarnings Growth Summary & Daily Growth Stock Investment Tips - sundaytimes.kr
Spyre Therapeutics Inc. stock retracement – recovery analysisTake Profit & Consistent Growth Equity Picks - Newser
How hedge fund analytics apply to Spyre Therapeutics Inc. stockEarnings Beat & Accurate Technical Buy Alerts - Newser
Custom Dashboard Highlights Spyre Therapeutics Inc. Price MomentumMarket Growth Report & Long-Term Growth Plans - kangso.co.kr
When is the best time to exit Spyre Therapeutics Inc.Market Performance Summary & Advanced Technical Signal Analysis - Newser
Analyzing net buyer seller activity in Spyre Therapeutics Inc.July 2025 Sector Moves & Fast Entry and Exit Trade Plans - Newser
How to build a dashboard for Spyre Therapeutics Inc. stock2025 Historical Comparison & Accurate Intraday Trade Tips - Newser
RSI + MACD Show Convergence for Spyre Therapeutics Inc.2025 Valuation Update & Consistent Income Trade Ideas - newsyoung.net
Spyre Therapeutics Inc (SYRE) 財務データ
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):